Comparative Analysis of Regulatory Pathways in Regenerative Medicine: A Benchmark Study of Japan’s Act on the Safety of Regenerative Medicine (ASRM) against Eight Asia-Pacific Jurisdictions
Comparative Analysis of Regulatory Pathways in Regenerative Medicine: A Benchmark Study of Japan’s Act on the Safety of Regenerative Medicine (ASRM) against Eight Asia-Pacific Jurisdictions. // Cytotherapy. – URL: https://www.sciencedirect.com/science/article/pii/S1465324926010273?dgcid=rss_sd_all
Comparative Analysis of Regulatory Pathways in Regenerative Medicine: A Benchmark Study of Japan’s Act on the Safety of Regenerative Medicine (ASRM) against Eight Asia-Pacific Jurisdictions. Cytotherapy. https://www.sciencedirect.com/science/article/pii/S1465324926010273?dgcid=rss_sd_all
“Comparative Analysis of Regulatory Pathways in Regenerative Medicine: A Benchmark Study of Japan’s Act on the Safety of Regenerative Medicine (ASRM) against Eight Asia-Pacific Jurisdictions.” Cytotherapy.
@article{article42980,
title = {Comparative Analysis of Regulatory Pathways in Regenerative Medicine: A Benchmark Study of Japan’s Act on the Safety of Regenerative Medicine (ASRM) against Eight Asia-Pacific Jurisdictions},
journal = {Cytotherapy},
url = {https://www.sciencedirect.com/science/article/pii/S1465324926010273?dgcid=rss_sd_all}
}